Table 2 MR results in circulating metabolites from cohort 2
Outcome | Exposure | Method | SNPs | OR | 95% CI | P value |
|---|---|---|---|---|---|---|
Asthma | 2-Tetradecenoyl carnitine | Wald ratio | 1 | 0.076 | 0.020–0.289 | 1.54E-04 |
|  | Acetylcarnitine | Wald ratio | 1 | 0.023 | 0.003–0.163 | 1.54E-04 |
|  | Oleoylcarnitine | Wald ratio | 1 | 16.871 | 3.826–74.407 | 1.90E-04 |
|  | Palmitoylcarnitine | Wald ratio | 1 | 23.024 | 4.434–119.559 | 1.90E-04 |